Source: International Congress 2015 – Outcomes of lung transplantation
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Patrick Hofmann (Kaltbrunn, Switzerland), Patrick Hofmann, Michael Hombach, Macé Schuurmans, Urs Bürgi, Bruno Isenring, Nicolas Müller, Malcolm Kohler, Christian Benden, Lars Huber. Isolation of stenotrophomonas maltophilia in lung transplant recipients: effects of treatment on prevalence and outcome. Eur Respir J 2015; 46: Suppl. 59, 4554

Member's Comments

No comment yet.

Related content which might interest you: Carbapenem-resistant Klebsiella pneumoniae in lung transplant recipients: A case series Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 Nocardia infections in lung transplant recipients (LxTR) Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Non-tuberculous mycobacterium infection in lung transplant recipients Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 A case series of fidaxomicin for treatment of Clostridium difficile infection (CDI) in lung transplant (LTx) recipients Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Nocardia infections after lung transplantation: A case series Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Azole plasma concentrations in lung transplant recipients Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Severe infection due to corynebacterium striatum or amycolatum in 6 lung transplanted patients Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Fungal re-colonization in cystic fibrosis or bronchiectasis patients after lung transplantation: Incidence, time of onset and related-factors Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 LATE-BREAKING ABSTRACT: Pseudomonas aeruginosa strain prevalence, adaptation and diversification, during chronic lung infections of UK non-cystic fibrosis bronchiectasis patients Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 First reported case of disseminated talaromyces marneffei infection in a lung transplant patient Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Could nan1-expression and production by pseudomonas aeruginosa be a prognostic factor for survival in CF patients Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Aspergillus infections in lung transplant recipients. Risk factors and outcome Source: Eur Respir J 2004; 24: Suppl. 48, 178s Year: 2004 Hypogammaglobulinemia in lung transplant candidates Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Azithromycin therapy and pseudomonas aeruginosa isolation in a non-cystic fibrosis bronchiectasis cohort Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Fungal infections in transplant recipients Source: Eur Respir J 2001; 17: 133-140 Year: 2001 Early and late viral infections after lung transplantation Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Pseudomonas aeruginosa colonisation in patients without bronchiectasis Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Mesenchymal stem cells enhance bacterial clearance of streptococcal pneumoniae and pseudomonas aeruginosa in the lung Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016